These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9084923)

  • 1. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents.
    Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1997; 43(2):137-41. PubMed ID: 9084923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones.
    Tanaka G; Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1999; 45(1):28-36. PubMed ID: 9876207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method.
    Shigeta M; Tanaka G; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1997; 43(5):340-5. PubMed ID: 9309367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
    Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
    Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
    Delissalde F; Amábile-Cuevas CF
    Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clarithromycin on Pseudomonas aeruginosa biofilms.
    Tanaka G; Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 2000; 46(1):36-42. PubMed ID: 10601796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine.
    Goto T; Nakame Y; Nishida M; Ohi Y
    Urology; 1999 May; 53(5):1058-62. PubMed ID: 10223506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
    Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
    Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Roizman D; Vidaillac C; Givskov M; Yang L
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
    Harrison JJ; Turner RJ; Ceri H
    Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofilm susceptibility to metal toxicity.
    Harrison JJ; Ceri H; Stremick CA; Turner RJ
    Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections.
    Noreddin AM; Elkhatib WF
    J Infect Public Health; 2009; 2(3):120-8. PubMed ID: 20701871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of ciprofloxacin against Pseudomonas aeruginosa planktonic and biofilm-derived cells.
    Marques CNH; Nelson SM
    Lett Appl Microbiol; 2019 Apr; 68(4):350-359. PubMed ID: 30740751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of shear stress on growth, adhesion and biofilm formation of Pseudomonas aeruginosa with antibiotic-induced morphological changes.
    Fonseca AP; Sousa JC
    Int J Antimicrob Agents; 2007 Sep; 30(3):236-41. PubMed ID: 17574822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
    Viganor L; Galdino AC; Nunes AP; Santos KR; Branquinha MH; Devereux M; Kellett A; McCann M; Santos AL
    J Antimicrob Chemother; 2016 Jan; 71(1):128-34. PubMed ID: 26416778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
    Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.
    Manavathu EK; Vager DL; Vazquez JA
    BMC Microbiol; 2014 Mar; 14():53. PubMed ID: 24588809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.